Jens Juul Holst

Jens Juul Holst

Professor


  1. 2004
  2. Published

    Antihyperglycemic effects of stevioside in type 2 diabetic subjects. / Gregersen, Søren; Jeppesen, Per B; Holst, Jens Juul; Hermansen, Kjeld.

    In: Metabolism, Vol. 53, No. 1, 01.2004, p. 73-6.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Cholecystokinin inhibits gastrin secretion independently of paracrine somatostatin secretion in the pig. / Schmidt, P T; Hansen, L; Hilsted, L; Holst, Jens Juul.

    In: Scandinavian Journal of Gastroenterology, Vol. 39, No. 3, 03.2004, p. 217-21.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Incretins, insulin secretion and Type 2 diabetes mellitus. / Vilsbøll, T; Holst, Jens Juul.

    In: Diabetologia, Vol. 47, No. 3, 03.2004, p. 357-66.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes. / Meier, Juris J; Weyhe, Dirk; Michaely, Mark; Senkal, Metin; Zumtobel, Volker; Nauck, Michael A; Holst, Jens Juul; Schmidt, Wolfgang E; Gallwitz, Baptist.

    In: New Horizons (Baltimore), Vol. 32, No. 3, 03.2004, p. 848-51.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. / Näslund, Erik; King, N; Mansten, S; Adner, N; Holst, Jens Juul; Gutniak, M; Hellström, P M.

    In: The British Journal of Nutrition, Vol. 91, No. 3, 03.2004, p. 439-46.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. / Meier, Juris J; Goetze, Oliver; Anstipp, Jens; Hagemann, Dirk; Holst, Jens Juul; Schmidt, Wolfgang E; Gallwitz, Baptist; Nauck, Michael A.

    In: American Journal of Physiology: Endocrinology and Metabolism, Vol. 286, No. 4, 04.2004, p. E621-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. / Nagell, C F; Wettergren, A; Pedersen, J F; Mortensen, D; Holst, Jens Juul.

    In: Scandinavian Journal of Gastroenterology, Vol. 39, No. 4, 04.2004, p. 353-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. / Nauck, Michael A; Walberg, Jörg; Vethacke, Arndt; El-Ouaghlidi, Andrea; Senkal, Metin; Holst, Jens J; Gallwitz, Baptist; Gallwitz, J Baptist; Schmidt, Wolfgang E; Schmiegel, W.

    In: Regulatory Peptides, Vol. 118, No. 1-2, 15.04.2004, p. 89-97.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. / Hansen, Lene; Hartmann, Bolette; Mineo, Hitoshi; Holst, Jens Juul.

    In: Regulatory Peptides, Vol. 118, No. 1-2, 15.04.2004, p. 11-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors. / Hansotia, Tanya; Baggio, Laurie L; Delmeire, Dominique; Hinke, Simon A; Yamada, Yuichiro; Tsukiyama, Katsushi; Seino, Yutaka; Holst, Jens Juul; Schuit, Frans; Drucker, D J.

    In: Diabetes, Vol. 53, No. 5, 05.2004, p. 1326-35.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207